Table 1.
Results from ROI analysis from the rodent model of stroke.
| Feature | Ipsilateral | Contralateral | p-value |
|---|---|---|---|
| TTPPyruvate (s) | 4.5 ± 0.6 | 3.9 ± 0.2 | >0.05 |
| TTPDSC (s) | 6 ± 0.5 | 7 ± 0.5 | > 0.05 |
| CBVPyruvate (mL/100g) | 1.5 ± 0.4 | 0.9 ± 0.01 | > 0.05 |
| CBVDSC (mL/100g) | 4.8 ± 0.5 | 4.1 ± 0.9 | > 0.05 |
| CBFPyruvate (mL/100g/min) | 140 ± 2 | 89 ± 6 | < 0.01* |
| CBFDSC (mL/100g/min) | 106 ± 8 | 86 ± 5 | 0.03* |
| MTTPyruvate (s) | 6 ± 1 | 6 ± 1 | > 0.05 |
| MTTDSC (s) | 1.4 ± 0.3 | 0.97 ± 0.04 | > 0.05 |
| MCR (/s) | 0.17 ± 0.04 | 0.16 ± 0.01 | > 0.05 |
| Lactate:Pyruvate | 2.7 ± 0.2 | 2.1 ± 0.2 | 0.04* |
| FM (%) | 26 ± 5 | 4 ± 2 | < 0.01* |
* Statistically significant.